---
title: "Silexion Therapeutics (SLXN.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/SLXN.US/norm.md"
symbol: "SLXN.US"
name: "Silexion Therapeutics"
parent: "https://longbridge.com/zh-HK/quote/SLXN.US.md"
datetime: "2026-06-13T15:00:51.341Z"
locales:
  - [en](https://longbridge.com/en/quote/SLXN.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SLXN.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SLXN.US/norm.md)
---

# Silexion Therapeutics (SLXN.US) — 財務報表

## 損益表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -8.46 | -14.02 | -28.80 | -38.39 | -161.53 |
| ROE | -755.49% | -368.43% | - | 989.31% | 163.12% |
| 營業收入 | - | - | - | - | - |
| 凈利潤 | -2.73M | -4.41M | -3.26M | -1.74M | -1.75M |
| 營業利潤 | -2.75M | -4.41M | -3.29M | -1.65M | -1.90M |
| 毛利率 | - | - | - | - | - |
| 凈利率 | - | - | - | - | - |
| 利潤含金量 | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 4.60M | 7.21M | 11.61M | 8.31M | 2.86M |
| 權益乘數 | 15.81 | 2.77 | 1.66 | 3.21 | -0.7177 |
| 每股凈資產 | 0.8572 | 8.33 | 22.31 | 44.63 | -323.65 |
| 資產周轉率 | - | - | - | - | - |
| 現金及短投 | 2.41M | 5.99M | 9.24M | 6.15M | 1.19M |
| 存貨與應收 | - | - | - | - | - |
| 長期投資 | 403000.00 | 437000.00 | 468000.00 | 534000.00 | 560000.00 |
| 凈債務 | -424000.00 | -3.96M | -7.22M | -2.67M | 3.30M |

## 現金流量表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -3.65M | -3.02M | -2.84M | -2.45M | -2.93M |
| 投資現金流 | - | -7000.00 | - | -6000.00 | 0.0000 |
| 融資現金流 | 83000.00 | -221000.00 | 8.62M | 7.43M | 2.18M |
| 自由現金流 | -2.63M | -1.58M | - | -1.64M | -2.18M |
| 現金流充裕率 | - | -150800.00% | - | -349.43% | -1170.40% |
| 舉債與償債 | - | - | - | - | - |
| 資本支出 | - | -2000.00 | - | -6000.00 | 0.0000 |